- Cosmetic toxicologist at Euverify, specialising in cosmetic product safety, PIF and CPSR preparation, and regulatory compliance with EU and UK Cosmetic Regulations. Conducts toxicological assessments of cosmetic ingredients and formulations, reviews product safety reports and manages CPNP and SCPN product notifications. Dedicated to supporting brands in achieving compliance with EU and UK cosmetic standards.
- March 11, 2026Industry Insights1% and Done: Understanding the New Kojic Acid Limit in EU and UK Cosmetics Law
- January 23, 2026Industry InsightsUV Filters in Cosmetics: EU & UK Compliance Risks Brands Must Watch
- December 19, 2025Industry InsightsFrom 26 to 80+ Fragrance Allergens: What EU & UK Cosmetic Brands Must Do Next
- November 7, 2025Industry InsightsNanomaterials in Cosmetics: How to Audit and Label Ingredients Under the New EU Rules
UV Filters in Cosmetics: EU & UK Compliance Risks Brands Must Watch
UV filters are some of the most tightly regulated cosmetic ingredients in Europe. That level of scrutiny exists for good reason. These ingredients are designed to interact directly with ultraviolet radiation, they are often used at relatively high concentrations, and they sit at a sensitive crossroads of consumer safety, product performance, and growing environmental attention.
For anyone formulating, importing, or selling SPF products, or any cosmetic that contains UV filters, in the EU or UK, enforcement issues are rarely surprising. Most problems trace back to the same few mistakes. The wrong filter is used. An approved filter is used incorrectly. nano requirements are missed. SPF or UVA claims are made without the data to properly support them.
What follows is a practical, risk-focused guide to help you stay on the right side of EU and UK rules.
The legal foundation: UV filters are positive-list ingredients in the EU
In the EU, UV filters are not treated like ordinary cosmetic ingredients. They are tightly controlled and sit in a category of their own. A UV filter can only be used if it appears in Annex VI of the EU Cosmetics Regulation, and even then, only under the exact conditions set out there. These conditions include maximum concentration limits, permitted product types, and any required warnings.
This structure is built directly into Regulation (EC) No 1223/2009, which regulates certain high-risk ingredient categories through specific annexes rather than leaving them to general safety assessment alone.
To check what is currently permitted, many companies rely on the ECHA “Cosmetics – UV filters” list. This list mirrors Annex VI and shows, for each UV filter, the applicable conditions and restrictions.
Why this matters is simple. if a substance is used for UV protection and does not appear in Annex VI, the product is not compliant in the EU. The same applies if the filter is listed but used outside the allowed limits.
EU Compliance Risks for UV Filters in Cosmetics
1) Using filters outside Annex VI — or using them as UV filters without realising it
A common trap sounds harmless enough:
“It’s in the formula, but it’s not there for SPF.”
In practice, that distinction rarely holds up. If an ingredient in your formulation absorbs UV radiation and is used to provide UV protection — even partially — regulators will treat it as a UV filter. Once that happens, Annex VI applies in full.
It does not matter whether the ingredient is positioned as the main SPF active or plays a supporting role. If it performs a UV-protective function, it must comply with Annex VI conditions.
This is where many products fall into trouble without realising it.
Risk management tips
- Build an Annex VI compliance check directly into your formulation process. Confirm the correct filter identity, INCI name, and maximum permitted concentration before finalising the formula.
- Be cautious with supplier claims of “global compliance.” Always cross-check against the official EU Annex VI listing, rather than relying on high-level assurances.
2) Exceeding maximum concentrations or ignoring product-type restrictions
Annex VI entries rarely give free rein. They are rarely as simple as “use up to X% anywhere.” Most come with specific conditions.
Some UV filters are limited to certain product types. Others are prohibited in sprays or aerosols. Some require mandatory warnings on the label.
A well-known example is Homosalate. Once widely used, it quickly became a compliance headache following SCCS safety conclusions and additional guidance. Commission Regulation (EU) 2022/2195 explicitly references those findings and tightened how Homosalate can be used.
The practical takeaway is clear:
even if a UV filter remains allowed, how, where, and how much you can use may change. Transition deadlines can force reformulation and relabelling, sometimes on very short notice.
3) Not keeping up with amendments — Annex VI is a moving target
Annex VI is updated regularly through new Commission Regulations. If your compliance process treats UV filters as “set-and-forget,” it is only a matter of time before non-compliant products reach the market.
Brands commonly miss key amendments. For example:
- Regulation (EU) 2022/1176 revised conditions for Benzophenone-3 and Octocrylene, including updated concentration limits and application timelines.
- Regulation (EU) 2024/996 introduced broader changes across multiple annexes, reflecting ongoing scrutiny of substances with potential endocrine-disrupting properties.
What good compliance looks like is straightforward in principle, but it requires consistency. Track Annex VI updates using authoritative sources such as EUR-Lex and the ECHA UV filter list.
Those updates should feed into a formal change-control process. That means assessing formulation impact, reviewing artwork, retesting stability or efficacy where needed, and planning sell-through of existing stock. Proactive monitoring prevents last-minute compliance surprises.
4) nano UV filters — labelling and documentation blind spots
nano forms of UV filters — such as certain forms of titanium dioxide or zinc oxide used for UV protection — can trigger additional obligations around transparency and safety assessment.
EU cosmetics rules include a specific framework for nanomaterials, covering definitions, assessment requirements, and regulatory oversight. The European Commission has also published guidance and reviews on how these provisions operate in practice.
There is also an important nuance to understand. Where a nanomaterial is used as a UV filter listed in Annex VI, the general nanomaterial notification rules interact with Annex VI in specific ways. This makes it critical that the nano UV filter used matches the exact specifications and conditions set out in the annex.
Common failure points
- Missing the required “(nano)” ingredient labelling where applicable.
- Using a nano UV filter variant that does not match Annex VI conditions (for example, coatings or specifications that fall outside the listing).
- Weak documentation in the Product Information File (PIF) to demonstrate compliance.
5) SPF and UVA claims that do not align with EU expectations
Even when a formula is fully compliant, claims can still create regulatory risk.
The EU has long-standing guidance on sunscreen efficacy and claims, designed to ensure consistency and help consumers make informed choices. This includes expectations around balanced UVA/UVB protection and clear, understandable labelling.
In parallel, all cosmetic claims must meet the EU’s common criteria. Claims must be truthful, supported by evidence, honest, fair, and enable informed decision-making, as set out in Commission Regulation (EU) No 655/2013.
Problematic claims tend to follow familiar patterns:
- “Blocks 100% of UV” — nearly impossible to substantiate and likely misleading.
- “All-day protection” — risky unless supported by robust evidence and clear reapplication context.
- UVA claims implying superior protection — problematic unless backed by the testing and UVA/UVB ratios expected under EU guidance.
The takeaway is simple:
a compliant formula can still become non-compliant if claims are not carefully aligned with EU expectations.
Emerging EU risk: Environmental scrutiny – octocrylene as a live example
Regulatory risk around UV filters is no longer limited to human safety alone. Environmental impact is playing an increasingly important role in how certain filters are assessed and regulated.
As of late 2025, ECHA opened a public consultation on a proposed restriction of octocrylene, a widely used UV filter. A consultation does not mean a ban is inevitable, but it is a clear signal of increased regulatory scrutiny.
For brands with octocrylene-heavy portfolios, this is a warning sign. Products relying on this filter should be treated as regulatory-change-sensitive, with early planning built into compliance and formulation strategies.
What brands should do now
- Map all SKUs containing octocrylene, including products where it is present at low concentrations as part of multi-filter systems.
- Develop and test alternative UV filter systems, assessing the impact on photostability, SPF performance, and UVA protection.
- Monitor EU regulatory timelines closely. Public consultations can progress into formal restriction proposals faster than many brands expect.
The key message is proactive preparation. Brands that wait until restrictions are formally adopted risk rushed reformulation, delayed market access, and unnecessary commercial disruption.
UK: How the risk picture changes (and where it doesn’t)
The UK largely follows the EU framework for cosmetic products. In Great Britain—which includes England, Scotland, and Wales—Regulation (EC) No 1223/2009 has been retained, but it is now enforced and administered at a national level. The UK has published statutory guidance explaining how the rules apply in practice and how compliance is monitored.
One important UK-specific requirement is product notification. Any cosmetic product made available to consumers in Great Britain must be notified through the Submit Cosmetic Product Notifications (SCPN) service, which is managed by the Office for Product Safety and Standards (OPSS).
Equally important, every cosmetic placed on the GB market must have a UK Responsible Person (RP). The RP is responsible for ensuring compliance and keeping product information up to date, including on SCPN and, where required, on product labelling.
Although the underlying rules closely mirror the EU regime, these operational differences are critical. Missing them is one of the most common reasons otherwise compliant products fall out of line in the UK.
UK Compliance Risks for UV Filters in Cosmetics
1) Assuming EU CPNP notification “covers the UK”
It doesn’t. Since Brexit, Great Britain uses SCPN, not the EU CPNP. If a product has only been notified through the EU system and not through SCPN, it is not compliant for the GB market.
This is one of the most common and easily avoidable compliance failures. Products can be fully compliant under EU rules and still be incorrectly placed on the GB market if SCPN notification is missing.
2) Missing the Great Britain vs Northern Ireland distinction
Northern Ireland operates under a different regime. It continues to follow the EU cosmetics framework as it applies in NI, while Great Britain applies the retained UK version of the regulation.
OPSS guidance makes it clear that there are separate rules for placing products across UK nations. If you sell in both Great Britain and Northern Ireland, you must manage two compliance routes correctly. Treating the UK as a single regulatory market is a common source of errors.
3) Preparing for future divergence — ingredient lists may drift
At present, EU and UK UV filter lists remain closely aligned because they originate from the same regulatory framework. However, over the medium term, divergence is a realistic possibility.
The safest approach is to plan for that now rather than react later. This means maintaining two regulatory baselines in your compliance system:
- one for EU Annex VI, updated as amendments are adopted, and
- one for the UK/GB retained version, incorporating any UK-specific changes as they emerge.
A Practical Compliance Checklist for UV Filter Products (EU + UK)
Formula and Ingredient Controls
- Verify every UV filter against Annex VI, ensuring it complies with:
- maximum concentration limits
- permitted product categories (for example, face vs body, sprays vs non-sprays)
- any required warnings or conditions of use
- Maintain an early-warning watchlist for UV filters under regulatory pressure, such as substances with endocrine disruption concerns or those subject to active review.
Documentation and Substantiation
- Keep the Product Information File (PIF) and Cosmetic Product Safety Report (CPSR) robust enough to demonstrate that the product is safe as used, particularly where UV filters are present at higher concentrations.
- Ensure all SPF, UVA, and related claims can be justified against:
- the EU common criteria for cosmetic claims, and
- EU sunscreen efficacy and labelling expectations.
Labelling and Claims Hygiene
- Avoid absolute or unqualified language such as “100% block” or “all-day protection” unless it can be clearly defended under the EU claims criteria.
- Align SPF and UVA messaging with the EU sunscreen Recommendation, including expectations around UVA/UVB balance and clarity for consumers.
UK Market Access Controls (Great Britain)
- Confirm that a UK Responsible Person (RP) is in place and correctly identified where required.
- Complete SCPN notification before placing any cosmetic product on the GB market.
Regulatory Change Monitoring
- Track EUR-Lex amendments affecting Annex VI and cross-check updates against the ECHA UV filter list.
- Monitor active regulatory processes, such as ECHA consultations, that could affect the future availability or conditions of use of key UV filters (for example, ongoing scrutiny of octocrylene).
Final Takeaway
UV filter compliance in the EU and UK is not just about having SPF test results on file. It is about managing an ingredient category that changes frequently and attracts close regulatory scrutiny.
Most brands run into trouble for the same predictable reasons. Annex VI is treated as static. Conditions and product-type limits are overlooked. nano requirements and supporting documentation are missed. Claims move faster than the evidence needed to support them.
The solution is not complicated, but it does require discipline. Build your compliance process around rigorous Annex VI verification, careful claims substantiation, and a robust Great Britain market access workflow, including a UK Responsible Person and SCPN notification..
Get those fundamentals right, and most of the avoidable compliance risk around UV filters disappears.
Related Resources
Medical
Industry Insights
Guides & Tutorials
Ecommerce
Guides & Tutorials
Cosmetics
Industry Insights
Amazon
Guides & Tutorials
UKCA
Guides & Tutorials